Zhiwen Xu

Title: Zhiwen Xu: Innovator in Neuropilin-2 Antibody Research

Introduction

Zhiwen Xu is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting neuropilin-2 (NRP2). With a total of 2 patents, his work focuses on therapeutic compositions that can modulate NRP2 activity, which is crucial for treating various diseases.

Latest Patents

Zhiwen Xu's latest patents include innovative compositions comprising anti-NRP2 antibodies. These patents provide affinity matured and humanized antibodies that specifically bind to human neuropilin-2 polypeptides. The antibodies are designed to modulate binding interactions between human NRP2 and its ligands, thereby influencing downstream signaling events associated with NRP2. His work also includes methods for treating NRP2-associated diseases, showcasing the therapeutic potential of these antibodies.

Career Highlights

Zhiwen Xu is currently associated with Atyr Pharma, Inc., where he continues to advance his research in antibody development. His expertise in the field has positioned him as a key player in the biotechnology sector, contributing to innovative solutions for complex medical challenges.

Collaborations

Zhiwen Xu collaborates with notable colleagues, including Luke Burman and David J King. These partnerships enhance the research environment and foster the development of groundbreaking therapeutic strategies.

Conclusion

Zhiwen Xu's contributions to the field of biotechnology, particularly through his patents on anti-NRP2 antibodies, highlight his role as an innovator in medical research. His work has the potential to significantly impact the treatment of diseases associated with neuropilin-2.